Details for New Drug Application (NDA): 208144
✉ Email this page to a colleague
NDA 208144 describes LUMIFY, which is a drug marketed by Bausch And Lomb Inc and is included in two NDAs. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the LUMIFY profile page.
The generic ingredient in LUMIFY is brimonidine tartrate. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
The generic ingredient in LUMIFY is brimonidine tartrate. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
Summary for 208144
| Tradename: | LUMIFY |
| Applicant: | Bausch And Lomb Inc |
| Ingredient: | brimonidine tartrate |
| Patents: | 4 |
Pharmacology for NDA: 208144
| Mechanism of Action | Adrenergic alpha-Agonists |
Medical Subject Heading (MeSH) Categories for 208144
Suppliers and Packaging for NDA: 208144
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LUMIFY | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 208144 | NDA | Bausch & Lomb Incorporated | 24208-537 | 24208-537-01 | 1 AMPULE in 1 CARTON (24208-537-01) / .4 mL in 1 AMPULE |
| LUMIFY | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 208144 | NDA | Bausch & Lomb Incorporated | 24208-537 | 24208-537-05 | 1 BOTTLE, DROPPER in 1 CARTON (24208-537-05) / 5 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.025% | ||||
| Approval Date: | Dec 22, 2017 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Jul 27, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | RELIEVES REDNESS OF THE EYE DUE TO MINOR EYE IRRITATIONS | ||||||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Jul 27, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | RELIEVES REDNESS OF THE EYE DUE TO MINOR EYE IRRITATIONS | ||||||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Jul 14, 2030 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | RELIEVES REDNESS OF THE EYE DUE TO MINOR EYE IRRITATIONS | ||||||||
Complete Access Available with Subscription
